Drug
HH-120 nasal spray
HH-120 nasal spray is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_2
1
25%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
completed375%
enrolling_by_invitation125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients
NCT05659602
enrolling_by_invitationphase_3
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
NCT05787418
completedphase_2
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
NCT05713318
completednot_applicable
A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19
NCT05747677
Clinical Trials (4)
Showing 4 of 4 trials
NCT05659602Not Applicable
A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients
NCT05787418Phase 3
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
NCT05713318Phase 2
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
NCT05747677Not Applicable
A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4